Full Length Research Paper
References
Aghaloo TL, Moy PK, Freymiller EG (2002). Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study. J. Oral Maxillofac. Surg. 60:1176-1181. Crossref |
||||
Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, Borojevic R (2013). Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem cell research & therapy 4:67-80. | ||||
Amaratunga NA (1988). Occurrence of oronasal fistulas in operated cleft palate patients. J. Oral Maxillofac Surg. 46:834-838. Crossref |
||||
Batra P, Sharma J, Duggal R, Parkash H (2004). Secondary bone grafting in cleft lip and palate with eruption of tooth into the graft: a case report. J. Indian Soc. Pedod. Prev. Dent. 22:8-12. Pubmed |
||||
Bostrom R, Mikos A (1997). Tissue engineering of bone. Birkhauser 215-234. | ||||
Bush JO, Jiang R (2012). Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development 139:231-243. Crossref |
||||
Chai Y, Maxson RE (2006). Recent advances in craniofacial morphogenesis. Dev. Dyn. 235:2353-2357. Crossref |
||||
Chin M, Ng T, Tom WK, Carstens M (2005). Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J. Craniofac. Surg. 16:778-789. Crossref |
||||
Cho HS, Song IH, Park SY, Sung MC, Ahn MW, Song KE (2011). Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J. Lab. Med. 31:212-218. Crossref |
||||
Cohen SR, Kalinowski J, LaRossa D, Randall P (1991). Cleft palate fistulas: a multivariate statistical analysis of prevalence, etiology, and surgical management. Plast Reconstr. Surg. 87:1041-1047. Crossref |
||||
Conejero JA, Lee JA, Parrett BM, Terry M, Wear-Maggitti K, Grant RT, Breitbart AS (2006). Repair of palatal bone defects using osteogenically differentiated fat-derived stem cells. Plast Reconstr. Surg. 117:857-863. Crossref |
||||
De Kok IJ, Peter SJ, Archambault M, van den Bos C, Kadiyala S, Aukhil I, Cooper LF (2003). Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: preliminary findings. Clin. Oral. Implants Res. 14:481-489. Crossref |
||||
De La Pedraja J, Erbella J, McDonald WS, Thaller S (2000). Approaches to cleft lip and palate repair. J. Craniofac. Surg. 11:562-571. Crossref |
||||
Desai HV, Voruganti IS, Jayasuriya C, Chen Q, Darling EM (2013). Live-cell, temporal gene expression analysis of osteogenic differentiation in adipose-derived stem cells. Tissue Eng. Part A 19:40-48. Crossref |
||||
Diao Y, Ma Q, Cui F, Zhong Y (2009). Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering. J. Biomed. Mater. Res. A 91:123-131. Crossref |
||||
Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB (2010). Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch. Oral Biol. 55:185-194. Crossref |
||||
Drengk A, Zapf A, Stürmer EK, Stürmer KM, Frosch KH (2009). Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 189:317-326. Crossref |
||||
Emory RE, Jr., Clay RP, Bite U, Jackson IT (1997). Fistula formation and repair after palatal closure: an institutional perspective. Plast Reconstr. Surg. 99:1535-1538. Crossref |
||||
Eto H, Suga H, Inoue K, Aoi N, Kato H, Araki J, Doi K, Higashino T, Yoshimura K (2011). Adipose injury-associated factors mitigate hypoxia in ischemic tissues through activation of adipose-derived stem/progenitor/stromal cells and induction of angiogenesis. Am. J. Pathol. 178:2322-2332. Crossref |
||||
Farina A, Wyszynski DF, Pezzetti F, Scapoli L, Martinelli M, Carinci F, Carls F, Nardelli GB, Tognon M, Carinci P (2002). Classification of oral clefts by affection site and laterality: a genotype-phenotype correlation study. Orthod. Craniofac. Res. 5:185-191. Crossref |
||||
Gimble JM, Katz AJ, Bunnell BA (2007). Adipose-derived stem cells for regenerative medicine. Circ. Res. 100:1249-1260. Crossref |
||||
Gruber R, Varga F, Fischer MB, Watzek G (2002). Platelets stimulate proliferation of bone cells: involvement of plateletderived growth factor, microparticles and membranes. Clin. Oral Impl. Res. 13:529-535. Crossref |
||||
Harris DT, Rogers I (2007). Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr. Stem Cell Res. Ther. 2:301-309. Crossref |
||||
Hibi H, Yamada Y, Ueda M, Endo Y (2006). Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac. Surg. 35:551-555. Crossref |
||||
Jamilian A, Nayeri F, Babayan A (2007). Incidence of cleft lip and palate in Tehran. J. Indian Soc. Pedod. Prev. Dent. 25:174-176. Crossref |
||||
Kanczler JM, Oreffo RO (2008). Osteogenesis and angiogenesis: the potential for engineering bone. Eur. Cell Mater. 15:100-114. Pubmed |
||||
Kang SW, Kim JS, Park KS, Cha BH, Shim JH, Kim JY, Cho DW, Rhie JW, Lee SH. 2011. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone 48:298-306. Crossref |
||||
Kim SH, Kim KH, Seo BM, Koo KT, Kim TI, Seol YJ, Ku Y, Rhyu IC, Chung CP, Lee YM (2009). Alveolar bone regeneration by transplantation of periodontal ligament stem cells and bone marrow stem cells in a canine peri-implant defect model: a pilot study. J. Periodontol. 80:1815-1823. Crossref |
||||
Landheer JA, Breugem CC, van der Molen AB (2010). Fistula incidence and predictors of fistula occurrence after cleft palate repair: two-stage closure versus one-stage closure. Cleft Palate Craniofac. J. 47:623-630. Crossref |
||||
Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H (2005). Engineering bone: challenges and obstacles. J. Cell Mol. Med. 9:72-84. Crossref |
||||
Luaces-Rey R, Arenaz-Bua J, Lopez-Cedrun-Cembranos JL, Herrero-Patino S, Sironvalle-Soliva S, Iglesias-Candal E, Pombo-Castro M. (2010). Is PRP useful in alveolar cleft reconstruction? Platelet-rich plasma in secondary alveoloplasty. Med. Oral Patol. Oral Cir. Bucal. 15:e619-623. Crossref |
||||
Marazita ML, Murray JC, Lidral AC, Arcos-Burgos M, Cooper ME, Goldstein T, Maher BS, Daack-Hirsch S, Schultz R, Mansilla MA, Field LL, Liu YE, Prescott N, Malcolm S, Winter R, Ray A, Moreno L, Valencia C, Neiswanger K, Wyszynski DF, Bailey-Wilson JE, Albacha-Hejazi H, Beaty TH, McIntosh I, Hetmanski JB, Tuncbilek G, Edwards M, Harkin L, Scott R, Roddick LG (2004). Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35. Am. J. Hum. Genet. 75:161-173. Crossref |
||||
Marukawa E, Oshina H, Iino G, Morita K, Omura K (2011). Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft. J. Craniomaxillofac. Surg. 39:278-283. Crossref |
||||
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998). Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral. Pathol. 85:638-646. Crossref |
||||
Marx RE (2001). Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 10:225-228. Crossref |
||||
Marx RE (2004). Platelet-rich plasma: evidence to support its use. J. Oral Maxillofac Surg. 62:489-496. Crossref |
||||
Méndez R, López-Cedrún J, Pati-o B, Vázquez I, Martín-Sastre R, Tellado M (2006). Platelet-rich plasma (platelet gel) in secondary alveoloplasty in cleft patients. Cir. Pediatr. 19:23-26. Pubmed |
||||
Meyer S, Molsted K (2013). Long-term outcome of secondary alveolar bone grafting in cleft lip and palate patients: A 10-year follow-up cohort study. J. Plast Surg. Hand Surg. | ||||
Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V, Jacobs CR. (2009). Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng. Part C Methods 15:431-435. Crossref |
||||
Mizuno H, Tobita M, Uysal AC (2012). Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem cells, 30:804-810. | ||||
Mylonas D, Vidal MD, De Kok IJ, Moriarity JD, Cooper LF (2007). Investigation of a thermoplastic polymeric carrier for bone tissue engineering using allogeneic mesenchymal stem cells in granular scaffolds. J. Prosthodont 16:421-430. Crossref |
||||
Nguyen PD, Lin CD, Allori AC, Schachar JS, Ricci JL, Saadeh PB, Warren SM (2009). Scaffold-based rhBMP-2 therapy in a rat alveolar defect model: implications for human gingivoperiosteoplasty. Plast Reconstr. Surg. 124:1829-1839. Crossref |
||||
Ohva M, Yamada Y, Ozawa R, Ito K, Takahashi M, Ueda M (2005). Sinus floor elevation applied tissue- engineered bone. Comparative study between mesenchymal stem cells/platelet rich plasma (PRP) and autogenous bone with PRP complexes in rabbits. Clin. Oral Impl. Res. 16:622-629. Crossref |
||||
Oprea WE, Karp JM, Hosseini MM, Davies JE (2003). Effect of platelet releasate on bone cell migration and recruitment in vitro. J. Craniofac. Surg. 14:292-300. Crossref |
||||
Ou XR, Jian XC, Lin G (2007). [An investigation of restoration of alveolar cleft with engineered bone]. Zhonghua Zheng Xing Wai Ke Za Zhi 23:29-31. Pubmed |
||||
Panetta NJ, Gupta DM, Slater BJ, Kwan MD, Liu KJ, Longaker MT. (2008). Tissue engineering in cleft palate and other congenital malformations. Pediatr. Res. 63:545-551. Crossref |
||||
Pourebrahim N, Hashemibeni B, Shahnaseri S, Torabinia N, Mousavi B, Adibi S, Heidari F, Alavi MJ (2013). A comparison of tissue-engineered bone from adipose-derived stem cell with autogenous bone repair in maxillary alveolar cleft model in dogs. Int J Oral Maxillofac. Surg. 42:562-568. Crossref |
||||
Rada T, Santos TC, Marques AP, Correlo VM, Frias AM, Castro AG, Neves NM, Gomes ME, Reis RL (2012). Osteogenic differentiation of two distinct subpopulations of human adipose-derived stem cells: an in vitro and in vivo study. J Tissue Eng. Regen Med. 6:1-11. Crossref |
||||
Ravari H, Hamidi-Almadari D, Salimifar M, Bonakdaran S, Parizadeh MR, Koliakos G (2011). Treatment of non-healing wounds with autologous bone marrow cells, platelets, fibrin glue and collagen matrix. Cytotherapy 13:705-711. Crossref |
||||
Roubelakis MG, Trohatou O, Roubelakis A, Mili E, Kalaitzopoulos I, Papazoglou G, Pappa KI, Anagnou NP (2014). Platelet-rich plasma (PRP) promotes fetal mesenchymal stem/stromal cell migration and wound healing process. Stem Cell Rev. 10:417-428. Crossref |
||||
Seghatoleslam M, Jalali M, Nikravesh MR, Hosseini M, Hamidi Alamdari D, Fazel A (2012). Therapeutic benefit of intravenous administration of human umbilical cord blood- mononuclear cells following intracerebral hemorrhage in rat. Iran J. Basic Med. Sci. 15:860-872. Pubmed |
||||
Shirvan MK, Alamdari DH, Ghoreifi A (2013a). A novel method for iatrogenic vesicovaginal fistula treatment: autologous platelet rich plasma injection and platelet rich fibrin glue interposition. J. Urol. 189:2125-2129. Crossref |
||||
Shirvan MK, Alamdari DH, Mahboub MD, Ghanadi A, Rahimi HR, Seifalian AM (2013b). A novel cell therapy for stress urinary incontinence, short-term outcome. Neurourol Urodyn 32:377-382. Crossref |
||||
Taha MF, Hedayati V. 2010. Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells. Tissue Cell 42:211-216. Crossref |
||||
Takano-Yamamoto T, Kawakami M, Sakuda M (1993). Defects of the rat premaxilla as a model of alveolar clefts for testing bone-inductive agents. J. Oral Maxillofac. Surg. 51:887-891. Crossref |
||||
Tobita M, Uysal AC, Ogawa R, Hyakusoku H, Mizuno H (2008). Periodontal tissue regeneration with adipose-derived stem cells. Tissue Eng Part A 14:945-953. Crossref |
||||
Tozum TF, Demiralp B (2003). Platelet-rich plasma: a promising innovation in dentistry. Journal 69:664. | ||||
van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA (2006). Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue engineering 12:3067-3073. Crossref |
||||
Waite PD, Waite DE (1996). Bone grafting for the alveolar cleft defect. Semin. Orthod. 2:192-196. Crossref |
||||
Woo EJ (2012). Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg 70:765-767. Crossref |
||||
Xie X, Wang Y, Zhao C, Guo S, Liu S, Jia W, Tuan RS, Zhang C (2012). Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials 33:7708-7018. Crossref |
||||
Zuk PA (2008). Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatr. Res. 63(5):478-486. Crossref |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0